Feng HR - Search Results

1

Unveiling major histocompatibility complex-mediated pan-cancer immune features by integrated single-cell and bulk RNA sequencing.

Feng HR, Shen XN, Zhu XM, Zhong WT, Zhu DX, Zhao J, Chen YJ, Shen F, Liu K, Liang L. Feng HR, et al. Cancer Lett. 2024 Aug 10;597:217062. doi: 10.1016/j.canlet.2024.217062. Epub 2024 Jun 13. Cancer Lett. 2024. PMID: 38878852

2

CQ sensitizes human pancreatic cancer cells to gemcitabine through the lysosomal apoptotic pathway via reactive oxygen species.

Fu Z, Cheng X, Kuang J, Feng H, Chen L, Liang J, Shen X, Yuen S, Peng C, Shen B, Jin Z, Qiu W. Fu Z, et al. Mol Oncol. 2018 Apr;12(4):529-544. doi: 10.1002/1878-0261.12179. Epub 2018 Mar 13. Mol Oncol. 2018. PMID: 29453806 Free PMC article.

3

Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer.

Cheng X, Feng H, Wu H, Jin Z, Shen X, Kuang J, Huo Z, Chen X, Gao H, Ye F, Ji X, Jing X, Zhang Y, Zhang T, Qiu W, Zhao R. Cheng X, et al. Cancer Lett. 2018 Sep 1;431:105-114. doi: 10.1016/j.canlet.2018.05.046. Epub 2018 May 30. Cancer Lett. 2018. PMID: 29859300 Free article.

4

ETS variant 5 promotes colorectal cancer angiogenesis by targeting platelet-derived growth factor BB.

Cheng X, Jin Z, Ji X, Shen X, Feng H, Morgenlander W, Ou B, Wu H, Gao H, Ye F, Zhang Y, Peng Y, Liang J, Jiang Y, Zhang T, Qiu W, Lu X, Zhao R. Cheng X, et al. Int J Cancer. 2019 Jul 1;145(1):179-191. doi: 10.1002/ijc.32071. Epub 2019 Jan 28. Int J Cancer. 2019. PMID: 30650178

5

Corrigendum to "Targeting autophagy enhances apatinib-induced apoptosis via endoplasmic reticulum stress for human colorectal cancer" [Cancer Lett. 431 (2018) 105-114].

Cheng X, Feng H, Wu H, Jin Z, Shen X, Kuang J, Huo Z, Chen X, Gao H, Ye F, Ji X, Jing X, Zhang Y, Zhang T, Qiu W, Zhao R. Cheng X, et al. Cancer Lett. 2019 Oct 1;461:156. doi: 10.1016/j.canlet.2019.05.020. Epub 2019 Jun 4. Cancer Lett. 2019. PMID: 31174903 No abstract available.

6

Potential Therapeutic Targets of B7 Family in Colorectal Cancer.

Wang C, Feng H, Cheng X, Liu K, Cai D, Zhao R. Wang C, et al. Front Immunol. 2020 May 5;11:681. doi: 10.3389/fimmu.2020.00681. eCollection 2020. Front Immunol. 2020. PMID: 32477326 Free PMC article. Review.

7

Identification and validation of critical alternative splicing events and splicing factors in gastric cancer progression.

Feng H, Jin Z, Liu K, Peng Y, Jiang S, Wang C, Hu J, Shen X, Qiu W, Cheng X, Zhao R. Feng H, et al. J Cell Mol Med. 2020 Nov;24(21):12667-12680. doi: 10.1111/jcmm.15835. Epub 2020 Sep 16. J Cell Mol Med. 2020. PMID: 32939931 Free PMC article.

8

Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5⁺ colorectal cancer.

Feng H, Liu K, Shen X, Liang J, Wang C, Qiu W, Cheng X, Zhao R. Feng H, et al. Cell Death Dis. 2020 Oct 24;11(10):916. doi: 10.1038/s41419-020-03111-7. Cell Death Dis. 2020. PMID: 33099574 Free PMC article.

9

Correction: Targeting tumor cell-derived CCL2 as a strategy to overcome Bevacizumab resistance in ETV5⁺ colorectal cancer.

Feng H, Liu K, Shen X, Liang J, Wang C, Qiu W, Cheng X, Zhao R. Feng H, et al. Cell Death Dis. 2020 Nov 23;11(11):1006. doi: 10.1038/s41419-020-03208-z. Cell Death Dis. 2020. PMID: 33230188 Free PMC article.

10

The role of E26 transformation-specific variant transcription factor 5 in colorectal cancer cell proliferation and cell cycle progression.

Peng Y, Feng H, Wang C, Song Z, Zhang Y, Liu K, Cheng X, Zhao R. Peng Y, et al. Cell Death Dis. 2021 Apr 30;12(5):427. doi: 10.1038/s41419-021-03717-5. Cell Death Dis. 2021. PMID: 33931578 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

53 results

Search Page

Filters